2-((5-Chlorothiophen-2-yl)ethynyl)-N-(3,4-dihydroxyphenethyl)-9H-purin-6-amine

ID: ALA4581568

PubChem CID: 155561439

Max Phase: Preclinical

Molecular Formula: C19H14ClN5O2S

Molecular Weight: 411.87

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  Oc1ccc(CCNc2nc(C#Cc3ccc(Cl)s3)nc3[nH]cnc23)cc1O

Standard InChI:  InChI=1S/C19H14ClN5O2S/c20-15-5-2-12(28-15)3-6-16-24-18(17-19(25-16)23-10-22-17)21-8-7-11-1-4-13(26)14(27)9-11/h1-2,4-5,9-10,26-27H,7-8H2,(H2,21,22,23,24,25)

Standard InChI Key:  OUDNABXHAKYWLX-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 28 31  0  0  0  0  0  0  0  0999 V2000
   28.1970  -31.3944    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   28.9066  -30.9849    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.9038  -30.1623    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   28.1952  -29.7570    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.4889  -30.9854    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.4856  -30.1689    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.7080  -29.9197    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   26.2307  -30.5822    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.7134  -31.2408    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   28.1925  -28.9398    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   28.8989  -28.5290    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.6134  -31.3906    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.3217  -31.7981    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.0301  -32.2056    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.1174  -33.0163    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.9170  -33.1849    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.3245  -32.4765    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.7767  -31.8702    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   33.1416  -32.4730    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   29.6079  -28.9353    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.3143  -28.5244    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.0220  -28.9329    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.7279  -28.5227    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.7257  -27.7047    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.0117  -27.2985    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.3088  -27.7111    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.0062  -26.4814    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   32.4316  -27.2928    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  5  1  1  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  6  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9  5  1  0
  4 10  1  0
 10 11  1  0
 12 13  3  0
  2 12  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 14  1  0
 17 19  1  0
 11 20  1  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 21  1  0
 25 27  1  0
 24 28  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4581568

    ---

Associated Targets(Human)

HTR2B Tclin Serotonin 2b (5-HT2b) receptor (10323 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRA2C Tclin Alpha-2c adrenergic receptor (4876 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADORA3 Tchem Adenosine A3 receptor (15931 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADORA2A Tclin Adenosine A2a receptor (16305 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADORA1 Tclin Adenosine A1 receptor (17603 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 411.87Molecular Weight (Monoisotopic): 411.0557AlogP: 3.53#Rotatable Bonds: 4
Polar Surface Area: 106.95Molecular Species: NEUTRALHBA: 7HBD: 4
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 4#RO5 Violations (Lipinski):
CX Acidic pKa: 9.27CX Basic pKa: 3.53CX LogP: 4.54CX LogD: 4.54
Aromatic Rings: 4Heavy Atoms: 28QED Weighted: 0.30Np Likeness Score: -0.34

References

1. Yu J, Mannes P, Jung YH, Ciancetta A, Bitant A, Lieberman DI, Khaznadar S, Auchampach JA, Gao ZG, Jacobson KA..  (2018)  Structure activity relationship of 2-arylalkynyl-adenine derivatives as human A3 adenosine receptor antagonists.,  (11): [PMID:30568760] [10.1039/C8MD00317C]

Source